Site icon Unither Pharmaceuticals

Advanced liquid solutions for better patient outcomes 

Flexible Packaging and Delivery Systems for the OTC Market

Unither Pharmaceuticals provides a wide range of customizable liquid delivery systems, ensuring flexible formulations and packaging to meet diverse ENT treatment needs. These solutions enhance both patient convenience and healthcare provider accuracy.

Customization for the OTC Market

In the competitive OTC market, product customization is essential. Unither’s liquid delivery systems offer numerous options to meet the unique needs of consumers and regulatory bodies, helping companies stand out in the market.

Enhancing Patient Adherence Through Convenience

From portable stick-packs to easy-to-use sprays and reliable BFS technology, advanced liquid delivery systems are transforming patient care. For chronic conditions like sinusitis or allergic rhinitis, these user-friendly options significantly boost treatment adherence. They are versatile across therapeutic areas, including:

These solutions simplify treatment routines, reducing missed doses and enabling consistent health outcomes. With the global respiratory care market valued at $49 billion, demand for efficient, patient-friendly delivery systems is rapidly growing.

Driving Innovation in the OTC Market

Simonne Farina, Head of OTC, Respiratory & Generic Business at Unither Pharmaceuticals, emphasizes the company’s dedication to innovation:

“At Unither Pharmaceuticals, our commitment to the OTC market extends beyond diverse delivery systems. Through co-development, licensing, and strategic subcontracting, we collaborate with our customers to create patient-centric solutions. Our products meet unique patient needs and align with trends in personalized and precision medicine.”

The global pharmaceutical market is expected to reach $1.8 trillion by 2027, driven by demand for tailored treatment solutions.

 

About Unither Pharmaceuticals

Unither Pharmaceuticals is a global leader in liquid formulations, specializing in advanced delivery systems for ENT treatments. Their production facility in Colomiers, France, focuses on developing nasal, ear, and buccal sprays, as well as bottles and stick-packs. Products comply with European cGMP regulations and hold ISO 13485 certification, ensuring high standards for safety and quality. With additional production sites in the USA, Brazil, and China, Unither offers a secure, flexible global supply chain to meet rising healthcare demands.

For more details about Unither’s ENT technologies and spray solutions, visit www.unither-pharma.com or contact Simonne Farina at contact@unither-pharma.com.

Exit mobile version